The first reported human clinical application of umbilical cord tissue-derived mesenchymal stem cells(MSCs) was recently published in Transplantation.(1) The study found that the use of cord tissue MSCs was feasible, safe and effective in treating patients with graft versus host disease (GvHD), which is a serious and potentially fatal complication of stem cell...